Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage / Q000627:therapeutic use*; D008750:Methyldopa / Q000008:administration & dosage / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D006834:Hydrazines; D008750:Methyldopa; D004295:Dihydroxyphenylalanine